E-mail us: service@prospectnews.com Or call: 212 374 2800
Bank Loans - CLOs - Convertibles - Distressed Debt - Emerging Markets
Green Finance - High Yield - Investment Grade - Liability Management
Preferreds - Private Placements - Structured Products
 
Published on 6/26/2022 in the Prospect News Structured Products Daily.

New Issue: Morgan Stanley prices $982,000 13.75% contingent income autocalls on ETFs

By Kiku Steinfeld

Chicago, June 27 – Morgan Stanley Finance LLC priced $982,000 of contingent income autocallable securities due Dec. 19, 2023 linked to the SPDR S&P Biotech ETF and Energy Select Sector SPDR fund, according to a 424B2 filing with the Securities and Exchange Commission.

Investors will receive a coupon of 13.75%, paid quarterly, if each underlying fund closes at or above its 75% coupon barrier on the related quarterly observation date.

The securities will be called automatically starting June 14, 2022 at par if the price of each underlying fund is greater than or equal to its initial price on any quarterly call determination date.

At maturity the payout will be par unless the worst performing ETF closes below its 70% downside threshold level, in which case investors will be fully exposed to the decline of the worst performing ETF.

The notes are guaranteed by Morgan Stanley.

Morgan Stanley & Co. LLC is the agent.

Issuer:Morgan Stanley Finance LLC
Guarantor:Morgan Stanley
Issue:Contingent income autocallable securities
Underlying ETFs:SPDR S&P Biotech ETF and Energy Select Sector SPDR fund
Amount:$982,000
Maturity:Dec. 19, 2023
Coupon:13.75%, paid quarterly, if each underlying fund closes at or above its 75% coupon barrier on the related quarterly observation date
Price:Par
Payout at maturity:Par unless the worst performing ETF closes below its downside threshold level, in which case investors will be fully exposed to the decline in the worst performing ETF
Call:Automatically starting June 14, 2022 at par if the price of each underlying fund is greater than or equal to its initial price on any quarterly call determination date
Initial levels:$108.77 for Biotech, $55.42 for Energy
Downside thresholds:$76.139 for Biotech, $38.794 for Energy, 70% of initial levels
Coupon barrier:$81.578 for Biotech, $41.565 for Energy, 75% of initial levels
Pricing date:Dec. 14, 2021
Settlement date:Dec. 17, 2021
Agent:Morgan Stanley & Co. LLC
Fees:0.5%
Cusip:61773HTV1

© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.